Epidemiology and public health response in early phase of COVID-19 pandemic, Veneto Region, Italy, 21 February to 2 April 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
11 2020
Historique:
entrez: 27 11 2020
pubmed: 28 11 2020
medline: 15 12 2020
Statut: ppublish

Résumé

BackgroundVeneto was one of the Italian regions hit hardest by the early phase of the coronavirus disease (COVID-19) pandemic.AimThis paper describes the public health response and epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in the Veneto Region from 21 February to 2 April 2020.MethodsInformation on the public health response was collected from regional health authorities' official sources. Epidemiological data were extracted from a web-based regional surveillance system. The epidemic curve was represented by date of testing. Characteristics of hospitalised COVID-19 cases were described and compared to those never admitted to hospital. Age- and sex-stratified case-fatality ratios (CFRs) were calculated.ResultsKey elements of the regional public health response were thorough case-finding and contact tracing, home care for non-severe cases, creation of dedicated COVID-19 healthcare facilities and activation of sub-intensive care units for non-invasive ventilation. As at 2 April 2020, 91,345 individuals were tested for SARS-CoV-2 and 10,457 (11.4%) were positive. Testing and attack rates were 18.6 per 1,000 and 213.2 per 100,000 population, respectively. The epidemic peaked around 20 to 24 March, with case numbers declining thereafter. Hospitalised cases (n = 3,623; 34.6%) were older and more frequently male compared with never-hospitalised cases. The CFR was 5.6% overall, and was higher among males and people > 60 years of age.ConclusionIn the Veneto Region, the strict social distancing measures imposed by the Italian government were supported by thorough case finding and contact tracing, as well as well-defined roles for different levels of care.

Identifiants

pubmed: 33243356
doi: 10.2807/1560-7917.ES.2020.25.47.2000548
pmc: PMC7693165
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Science. 2020 May 8;368(6491):
pubmed: 32234805
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
J Cardiothorac Vasc Anesth. 2020 Sep;34(9):2341-2345
pubmed: 32425461
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
J Med Virol. 2020 Jun;92(6):639-644
pubmed: 32141619
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Lancet Infect Dis. 2020 Jul;20(7):756-757
pubmed: 32251637
N Engl J Med. 2020 Mar 26;382(13):1278-1280
pubmed: 32069388
J Microbiol Immunol Infect. 2020 Jun;53(3):404-412
pubmed: 32173241
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930
J Med Virol. 2020 Jun;92(6):568-576
pubmed: 32134116
Int J Infect Dis. 2020 May;94:154-155
pubmed: 32179137
BMJ. 2020 Mar 16;368:m1065
pubmed: 32179517
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265005
Lancet Infect Dis. 2020 Apr;20(4):410-411
pubmed: 32087116
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404

Auteurs

Francesca Russo (F)

Regional Directorate of Prevention, Food Safety, Veterinary Public Health, Regione del Veneto, Padova, Italy.

Gisella Pitter (G)

Screening and Health Impact Assessment Unit, Azienda Zero, Regione del Veneto, Padova, Italy.

Filippo Da Re (F)

Regional Directorate of Prevention, Food Safety, Veterinary Public Health, Regione del Veneto, Padova, Italy.
These authors contributed equally.

Michele Tonon (M)

Regional Directorate of Prevention, Food Safety, Veterinary Public Health, Regione del Veneto, Padova, Italy.
These authors contributed equally.

Francesco Avossa (F)

Regional Epidemiological Service Unit, Azienda Zero, Regione del Veneto, Padova, Italy.

Stefania Bellio (S)

Hygiene and Public Health Unit, Department of Cardiovascular Medicine and Public Health, University of Padova, Padova, Italy.

Ugo Fedeli (U)

Regional Epidemiological Service Unit, Azienda Zero, Regione del Veneto, Padova, Italy.

Lorenzo Gubian (L)

Informative Systems Unit, Azienda Zero, Regione del Veneto, Padova, Italy.

Daniele Monetti (D)

Regional Epidemiological Service Unit, Azienda Zero, Regione del Veneto, Padova, Italy.

Mario Saia (M)

Clinical Governance Unit, Azienda Zero, Regione del Veneto, Padova, Italy.

Francesca Zanella (F)

Regional Directorate of Prevention, Food Safety, Veterinary Public Health, Regione del Veneto, Padova, Italy.

Manuel Zorzi (M)

Regional Epidemiological Service Unit, Azienda Zero, Regione del Veneto, Padova, Italy.

Elena Narne (E)

Screening and Health Impact Assessment Unit, Azienda Zero, Regione del Veneto, Padova, Italy.

Domenico Mantoan (D)

Director General, Health and Social Area, Regione del Veneto, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH